Mirkin v. Wasserman

858 P.2d 568, 5 Cal. 4th 1082, 23 Cal. Rptr. 2d 101, 93 Daily Journal DAR 11610, 93 Cal. Daily Op. Serv. 6799, 1993 Cal. LEXIS 4451
CourtCalifornia Supreme Court
DecidedSeptember 9, 1993
DocketS020465
StatusPublished
Cited by251 cases

This text of 858 P.2d 568 (Mirkin v. Wasserman) is published on Counsel Stack Legal Research, covering California Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mirkin v. Wasserman, 858 P.2d 568, 5 Cal. 4th 1082, 23 Cal. Rptr. 2d 101, 93 Daily Journal DAR 11610, 93 Cal. Daily Op. Serv. 6799, 1993 Cal. LEXIS 4451 (Cal. 1993).

Opinions

Opinion

PANELLI, J.

We granted review to determine whether plaintiffs, who purchased securities at a price allegedly affected by misrepresentations, can plead a cause of action for deceit under Civil Code sections 1709 and 1710 without alleging that they actually relied on the misrepresentations. We hold that plaintiffs may not do so.

I. Facts

This case, which comes to us after the superior court sustained defendants’ demurrer, presents a pure question of law. The material allegations of the complaint, which we assume to be true for the purpose of reviewing such rulings (Garcia v. Superior Court (1990) 50 Cal.3d 728, 732 [268 Cal.Rptr. 779, 789 P.2d 960]), can be summarized briefly:

Plaintiffs Gerald Mirkin and Charles Miller purchased shares of the common stock of Maxi care Health Plans, Inc. (Maxicare) between October 17, 1985, and February 29, 1988. Plaintiffs purport to represent all persons who purchased the company’s common stock or its 11.75 percent senior subordinated notes during the same period of time. Defendants are Maxicare, which owned and operated health maintenance organizations in 14 states, including California; 12 of Maxi care’s officers and directors; Ernst & Whinney (succeeded by respondent Ernst & Young), the accounting firm that audited Maxicare’s financial statements; and Salomon Brothers, Inc. and Montgomery Securities, Inc., who together underwrote public offerings of Maxicare securities on November 26, 1985, and September 19, 1986.

Plaintiffs allege that Maxicare, after appearing to experience substantial growth and profits in 1985 and 1986, began to suffer large losses. Maxicare reported losses of $22 million for the fourth quarter of 1986, $255 million for the year 1987, and $21.3 million for the first quarter of 1988. During this period, the value of Maxicare stock gradually dropped from a high of $28.50 per share in 1986 to a low of $1.50 per share in 1988.

Plaintiffs also allege that defendants, beginning in 1985, made numerous misrepresentations about Maxicare’s prospects and financial status in prospectuses for the 1985 and 1986 public offerings, in documents filed with [1088]*1088the Securities Exchange Commission, and in other public communications. According to plaintiffs, these misrepresentations inflated the price of Maxi-care securities, thus allowing them to sell for more than their true value. Plaintiffs also allege that several of the individual defendants sold Maxicare securities to the public during the same period of time.

Plaintiffs’ first consolidated amended complaint purported to state causes of action for deceit and negligent misrepresentation.1 (Civ. Code, §§ 1709, 1710.) In attempting to plead actual reliance, which is an element of those torts (Molko v. Holy Spirit Assn. (1988) 46 Cal.3d 1092, 1108 [252 Cal.Rptr. 122, 762 P.2d 46]; Garcia v. Superior Court, supra, 50 Cal.3d at p. 737), plaintiffs alleged in conclusory fashion that they had purchased Maxicare securities “in reliance upon said misrepresentations.” Defendants demurred on the ground that the allegation of reliance was insufficient. When plaintiffs conceded they could not plead that they had actually read or heard the alleged misrepresentations, the court sustained the demurrers with leave to amend.

Plaintiffs attempted to cure the defect in an amended complaint by alleging that they had purchased shares “[i]n reliance upon the integrity of the securities market and the securities offering process, and the fidelity, integrity and superior knowledge of defendants . . . .” Once again finding plaintiffs’ pleading of reliance deficient, the court sustained defendants’ demurrers without leave to amend and dismissed the complaint.

On appeal, plaintiffs argued that the so-called “fraud-on-the-market” doctrine obviates the need to plead and prove actual reliance in cases where material misrepresentations are alleged to have affected the market price of stock. (See generally Basic Inc. v. Levinson (1988) 485 U.S. 224, 241-247 [99 L.Ed.2d 194, 214-218, 108 S.Ct. 978].) The Court of Appeal rejected the argument and affirmed the judgment of the superior court. We granted review.

II. Discussion

It is settled that a plaintiff, to state a cause of action for deceit based on a misrepresentation, must plead that he or she actually relied on the misrepresentation. (E.g., Molko v. Holy Spirit Assn., supra, 46 Cal.3d at p. 1108; Seeger v. Odell (1941) 18 Cal.2d 409, 414 [115 P.2d 977, 136 A.L.R. 1291]; Spinks v. Clark (1905) 147 Cal. 439, 444 [82 P. 45].) The law appears [1089]*1089always to have been so in this state. (See, e.g., Colton v. Stanford (1890) 82 Cal. 351, 383 [23 P. 16]; Nounnan v. Sutter County Land Co. (1889) 81 Cal. 1, 6-7 [22 P. 515]; Estep v. Armstrong (1886) 69 Cal. 536, 538 [11 P.2d 132]; Snow v. Halstead (1851) 1 Cal. 359, 361.)

The question before us is whether plaintiffs, who cannot allege that they actually read or heard the alleged misrepresentations, have pled a cause of action for deceit.2 Rather than relying on defendants’ statements about Maxicare and the value of its securities, plaintiffs allege that they “reli[ed] on the integrity of the securities market and the securities offering process, and the fidelity, integrity and superior knowledge of defendants . . . .” To justify their failure to plead actual reliance on the alleged misrepresentations, plaintiffs explain that the price of securities traded in an open and developed market, such as a national stock exchange, adjusts in response to material information, whether such information is true or false. In this way, plaintiffs assert, misrepresentations are reflected in the market price of a security, and someone who relies on the market price as indicating the actual value of a security relies, albeit indirectly, on the misrepresentations.

Based on this reasoning, which is sometimes called the fraud-on-the-market doctrine, the United States Supreme Court has held that “[i]t is not inappropriate to apply a presumption of reliance” in actions brought under rule 10b-5 of the Securities and Exchange Commission (SEC). (Basic Inc. v. Levinson, supra, 485 U.S. at pp. 241-247, 250 [99 L.Ed.2d at pp. 214-218, 220; see SEC Rule 10b-5, 17 C.F.R. § 240.10b-5 (1992) [hereafter Rule 10b-5].)

The characteristics of a private action under Rule 10b-5 are not derived from, or identical to, the common law of deceit. Rule 10b-5 was promulgated by the SEC under a broad, statutory grant of authority to adopt rules to prevent the use of “any manipulative or deceptive device or contrivance” in connection with the purchase or sale of securities. (Securities Exchange Act of 1934, § 10(b), 15 U.S.C. § 78j(b).) This enabling legislation was intended by Congress to be interpreted “ ‘flexibly to effectuate its remedial purposes.’ ” (Affiliated Ute Citizens v. United States (1972) 406 U.S. 128

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Naranjo v. Doctors Medical Center of Modesto
California Court of Appeal, 2023
Cheryl Albaugh v. The Reserve
930 N.W.2d 676 (Supreme Court of Iowa, 2019)
In re First American Home Buyers Protection Corp.
313 F.R.D. 578 (S.D. California, 2016)
Dampf v. BAC Home Loans Servicing CA2/7
California Court of Appeal, 2014
Szumilar v. Wells Fargo Bank CA2/1
California Court of Appeal, 2014
Hoffman v. 162 North Wolfe CA6
228 Cal. App. 4th 1178 (California Court of Appeal, 2014)
Heller v. Ralph's Grovery Co. CA2/5
California Court of Appeal, 2014
Hasso v. Hapke
227 Cal. App. 4th 107 (California Court of Appeal, 2014)
Marsh v. Anesthesia Services Medical Group CA4/1
California Court of Appeal, 2014
Alpineri v. TGG Management Co. CA4/1
California Court of Appeal, 2014
Christopher O'Shea v. Epson America, Inc.
566 F. App'x 605 (Ninth Circuit, 2014)
Marshall Block v. Ebay, Inc.
747 F.3d 1135 (Ninth Circuit, 2014)
Shalchi v. Brothers CA2/1
California Court of Appeal, 2014
Hart v. Wells Fargo Bank CA2/7
California Court of Appeal, 2013
Alimena v. Vericrest Financial, Inc.
964 F. Supp. 2d 1200 (E.D. California, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
858 P.2d 568, 5 Cal. 4th 1082, 23 Cal. Rptr. 2d 101, 93 Daily Journal DAR 11610, 93 Cal. Daily Op. Serv. 6799, 1993 Cal. LEXIS 4451, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mirkin-v-wasserman-cal-1993.